ShareValue scores for TRI.AU: Valuation 53, Quality 51, Growth 27, Health 60.
TRI.AUASX
Trivarx Ltd
A$0.02
(0.00%)
TRI.AUASX
Trivarx Ltd
A$0.02(0.00%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Weak
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
5% to 15%
Rating
Trap Risk
Return
5% to 15%
Valuation
53
Fair Value
Price vs Value
Quality
51
Moderate
Business Strength
Growth
27
Weak
Revenue & Earnings
Health
60
Moderate
Financial Stability
Momentum
67
Bullish
Price Trend
Company Details
About
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Hawthorn East, Australia.
Market Cap$23M
P/E Ratio-9.1
Dividend YieldNone
Sector Rank#2164
Score Analysis
AI Investment Thesis
Data as of:Jul 9, 2026
|Last calculated:Jul 9, 2026